In order to provide more information about the potential antileukemic action of violacein, in the present study we examined the effect of violacein on a chemoresistant CD34+/c-Kit+/P-glycoprotein+/MRP1+ TF1 leukaemia progenitor cell line. This evidence concerns the gene KIT and leukemia.